Studiengesellschaft BSF Unternehmergesellschaft

Halle 06108

1 studies enrolling now · 4 studies all time

What they study most

Moderate to Severe Ulcerative Colitis, SARS-CoV-2 Infection, COVID19, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis — Completed
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years — Completed